The First Macrolide-Resistant Bordetella pertussis Strains Isolated From Iranian Patients
Open Access
- 1 June 2014
- journal article
- research article
- Published by Brieflands in Jundishapur Journal of Microbiology
- Vol. 7 (6) , e10880
Abstract
Background: Whooping cough was considered as one of the major causes of childhood morbidity and mortality worldwide. Resistant isolates of Bordetella pertussis to macrolides in some countries have been recently reported. Objectives: Recent reports on macrolide-resistant B. pertussis isolates and lack of evidence for such resistance in clinical isolates of the Iranian patients led the authors of the current study to study antibiotic susceptibility of the collected isolates in the country. Susceptibility of the B. pertussis isolates to three antibiotics was studied. Relatedness of the strains recovered in this research was also examined. Materials and Methods: The antibacterial activities of erythromycin, azithromycin, and clarithromycin antibiotics against the recovered isolates of 779 nasopharyngeal swabs were examined using MIC (Minimum Inhibitory Concentration) method. Relationship of the strains was characterized by Pulsed-field Gel Electrophoresis (PFGE). Results: Among the specimens, 11 cases (1.4%) were culture-positive. Among these isolates, only two isolates had high MIC values for erythromycin and clarithromycin. Pulsed-field gel electrophoresis analysis of the isolates revealed 6 PFGE profiles (A-F) among which three and two isolates had the same patterns in profiles A and B, respectively. Conclusions: Azithromycin can be a good drug of choice to treat patients infected by B. pertussis in Iran. Clonal relationship of the isolates showed that the same B. pertussis strains were isolated from different patients in Iran. Keywords: Bordetella pertussis, Macrolides; PFGE; Antibiotic ResistanceKeywords
This publication has 30 references indexed in Scilit:
- Macrolide-Resistant Bordetella pertussis Infection in Newborn Girl, FranceEmerging Infectious Diseases, 2012
- Antimicrobial susceptibility testing of historical and recent clinical isolates of Bordetella pertussis in the United Kingdom using the Etest methodEuropean Journal of Clinical Microbiology & Infectious Diseases, 2010
- Problems associated with prophylactic use of erythromycin in 1566 staff to prevent hospital infection during the outbreak of pertussisJournal of Clinical Pharmacy and Therapeutics, 2009
- Analysis of Swedish Bordetella pertussis isolates with three typing methods: characterization of an epidemic lineageJournal of Microbiological Methods, 2009
- Emergence of Quinolone-Resistant Bordetella pertussis in JapanAntimicrobial Agents and Chemotherapy, 2009
- Antimicrobial susceptibility testing of Bordetella pertussis in Taiwan prompted by a case of pertussis in a paediatric patientJournal of Medical Microbiology, 2008
- Bordetella pertussis Strains Circulating in Europe in 1999 to 2004 as Determined by Pulsed-Field Gel ElectrophoresisJournal of Clinical Microbiology, 2007
- Is Bordetella pertussis susceptibility to erythromycin changing? MIC trends among Australian isolates 1971 2006Journal of Antimicrobial Chemotherapy, 2007
- What is new in pertussis?European Journal of Pediatrics, 2007
- Phenotypical and genotypical characterization of Bordetella pertussis strains isolated in São Paulo, Brazil, 1988-2002Revista do Instituto de Medicina Tropical de São Paulo, 2007